Dear customer, upon your request Andexxa Company were found the following resources. Our team makes effort to make you happy with the search on our site ninan.org

Andexxa – Andexxa

ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.…

About Andexxa

ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.…

Request an Andexxa Representative – Andexxa

ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.…

Portola Announces Preliminary Full Year 2019 Andexxa ...

Jan 09, 2020 · The Company's first two commercialized products are Andexxa ®  [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya ®  (andexanet alfa), and Bevyxxa ®  (betrixaban). The company also is advancing cerdulatinib, a SYK/JAK inhibitor being developed for the treatment of hematologic cancers.…